No announcements.
If I had to speculate on CUV recent rises-
1. Recent interest / takeover action in Australian Biotech. sector
2. Hopeful of imminent approval in USA
3. Improved sales in Europe
4. Potential for topical application for Scenesse (They recently bought 100% of company in Singapore who are developing this product)
A "best case" scenario would see CUV eventually become a multi billion dollar company, with obvious implications for the share price.
No announcements. If I had to speculate on CUV recent rises- 1....
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $741.1M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
